| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/19/2002 | EP1214317A1 Antiviral agents |
| 06/19/2002 | EP1214314A2 Aminopiperidine derivatives as antibacterials |
| 06/19/2002 | EP1214313A2 Heteroaryloxy propanolamines, preparation method and pharmaceutical compositions containing same |
| 06/19/2002 | EP1214312A1 5-aminoalkyl and 5-aminocarbonyl substituted indoles |
| 06/19/2002 | EP1214305A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 06/19/2002 | EP1214304A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 06/19/2002 | EP1214303A1 Heterocyclic compounds and methods of use thereof |
| 06/19/2002 | EP1214299A1 Muscarinic antagonists |
| 06/19/2002 | EP1214292A1 Tyrosine derivatives |
| 06/19/2002 | EP1214062A2 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists |
| 06/19/2002 | EP0980354B1 Vitamin d3 analogs with bis c-20 side chains |
| 06/19/2002 | EP0975623B1 Indazole amide compounds as serotoninergic agents |
| 06/19/2002 | EP0754061B1 New oral pharmaceutical dosage form |
| 06/19/2002 | CN1354740A Pharmaceutical compounds |
| 06/19/2002 | CN1086387C N-(aryloxyalkyl)heteroarylpiperidines and heteroarylpiperazines, their preparing method and their use as medicine |
| 06/19/2002 | CN1086386C Multi-drug resistance modifier |
| 06/18/2002 | US6407256 Cyano-pyrrole, cyano-imidazole, cyano-pyrazole, and cyano-triazole compounds as factor Xa inhibitors |
| 06/18/2002 | US6407249 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group |
| 06/18/2002 | US6407248 α-unsaturated amines, their production and use |
| 06/18/2002 | US6407242 Reacting a phthalimide compound with a quinoline compound;electroluminescence |
| 06/18/2002 | US6407217 Imidazolinone haptens and antigens and enzyme conjugates prepared therefrom |
| 06/18/2002 | US6407130 Antiallergens, antiinflammatory and antiarthritic agents; respiratory system, gastrointestinal disorders |
| 06/18/2002 | US6407123 Diaminopyridine-containing thiourea inhibitors of herpes viruses |
| 06/18/2002 | US6407121 Dopamine d4 receptor antagonists; psychological and brain disorders; alzheimer*s disease, schizophrenia; side effect reduction |
| 06/18/2002 | US6407116 2,4-dioxo-1,2,3,4-tetrahydroquinazoline derivatives; antiallergens, antiasthmatics, antihistamines, and antiinflammatory agents |
| 06/18/2002 | US6407111 Phenyl substituted pyridine and benzene derivatives |
| 06/18/2002 | US6407109 Antiepiletic, antidepressant, and anxiolytic agents; psychological and nervous system disorders |
| 06/18/2002 | US6407106 For therapy of inflammatory disturbances of the gastrointestinal tract |
| 06/18/2002 | US6407103 Potent enzyme inhibitors of cyclin-dependent kinases relating to the catalytic subunits cdk1-9 and their regulatory subunits cyclins a-h; antiproliferative, -carcinogenic and -tumor agents; viricides; modulators of dna/rna biosynthesis |
| 06/18/2002 | US6407102 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation |
| 06/18/2002 | US6407094 Glutamate receptor antagonists |
| 06/18/2002 | US6407087 UCF116 derivatives |
| 06/18/2002 | US6407080 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors |
| 06/18/2002 | CA2238140C Imidazole, triazole and tetrazole derivatives |
| 06/18/2002 | CA2059088C Pesticidal 1-(2-pyridyl)pyrazoles |
| 06/18/2002 | CA1341370C Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents |
| 06/13/2002 | WO2002046184A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 06/13/2002 | WO2002046183A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 06/13/2002 | WO2002046182A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors |
| 06/13/2002 | WO2002046181A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | WO2002046172A2 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | WO2002046171A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 06/13/2002 | WO2002046170A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 06/13/2002 | WO2002046162A1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 06/13/2002 | WO2002046161A1 Substituted carboxylic acid derivatives |
| 06/13/2002 | WO2002046160A2 Process for making a thrombin inhibitor |
| 06/13/2002 | WO2002046159A1 Guanidine and amidine derivatives as factor xa inhibitors |
| 06/13/2002 | WO2002046158A2 Piperidine/piperazine-type inhibitors of p38 kinase |
| 06/13/2002 | WO2002046155A1 Synthesis of fused pyrrolecarboxamides |
| 06/13/2002 | WO2002046151A1 Delta 1-pyrrolines used as pesticides |
| 06/13/2002 | WO2002046141A2 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 06/13/2002 | WO2002028842A3 Diazacycloalkanedione derivatives which are useful as lfa-1 antagonist |
| 06/13/2002 | WO2002024686A3 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 06/13/2002 | WO2002020011A3 A method for treating allergies using substituted pyrazoles |
| 06/13/2002 | WO2002019967A3 Substituted hydrazine derivatives |
| 06/13/2002 | WO2002016362A3 Nitrogenous heterocyclic compounds |
| 06/13/2002 | WO2002016361A3 Nitrogenous heterocyclic compounds |
| 06/13/2002 | WO2002016360A3 Nitrogenous heterocyclic compounds |
| 06/13/2002 | WO2002014315A3 Substituted pyrazoles |
| 06/13/2002 | WO2002008222A3 HETEROARYL-β-ALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS |
| 06/13/2002 | WO2002006221A3 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists |
| 06/13/2002 | WO2002000651A3 Factor xa inhibitors |
| 06/13/2002 | WO2001098277A3 Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 06/13/2002 | WO2001090104A3 -(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 06/13/2002 | WO2001079198B1 Pyrazoles for inhibiting protein kinase |
| 06/13/2002 | WO2001072721A3 Synergistic methods and compositions for treating cancer |
| 06/13/2002 | US20020072616 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 06/13/2002 | US20020072611 Antipsychotic heterocycle compounds |
| 06/13/2002 | US20020072608 Cis-substituted fluoromethylpyrrolidine derivative |
| 06/13/2002 | US20020072603 Novel IL-5 inhibiting 6-azauracil derivatives |
| 06/13/2002 | US20020072586 Chiral peptide nucleic acids |
| 06/13/2002 | US20020072529 For therapy and prophylaxis of cerebral apoplexy and craniocerebral trauma |
| 06/13/2002 | US20020072526 Orally active salts with tyrosine kinase activity |
| 06/13/2002 | US20020072521 For therapy of central nervous system disorders such as stress, anxiety, depression, cardiovascular disorders, and eating disorders |
| 06/13/2002 | US20020072520 For use in therapy of hyperlipidemia and arteriosclerotic disorders |
| 06/13/2002 | US20020072518 Bicyclic alphavbeta3 antagonists |
| 06/13/2002 | US20020072517 Substituted cyclic amine metalloprotease inhibitors |
| 06/13/2002 | US20020072081 Geranylgeranyl transferase inhibitor screening assay |
| 06/13/2002 | CA2436662A1 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | CA2431166A1 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 06/13/2002 | CA2431005A1 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 06/13/2002 | CA2430966A1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 06/13/2002 | CA2430951A1 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | CA2430846A1 Substituted carboxylic acid derivatives |
| 06/13/2002 | CA2430842A1 Process for making a thrombin inhibitor |
| 06/13/2002 | CA2430841A1 Synthesis of fused pyrrolecarboxamides |
| 06/13/2002 | CA2430683A1 Delta 1-pyrrolines |
| 06/13/2002 | CA2430376A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors |
| 06/13/2002 | CA2429258A1 Piperidine/piperazine-type inhibitors of p38 kinase |
| 06/12/2002 | EP1213289A1 N-benzenesulfonyl L-proline compounds as bradykinin antagonists |
| 06/12/2002 | EP1213283A2 Biphenyl-substituted triazines as light stabilisers |
| 06/12/2002 | EP1213281A1 Novel amide derivatives |
| 06/12/2002 | EP1213015A1 Oral pharmaceutical composition with delayed release of proton pump inhibitors |
| 06/12/2002 | EP1212486A1 Chlorohydrin and cationic compounds having high affinity for pulp or paper |
| 06/12/2002 | EP1212320A2 Phenylpiperazines as serotonin reuptake inhibitors |
| 06/12/2002 | EP1212319A2 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission |
| 06/12/2002 | EP1212318A1 Substituted indolinones as tyrosine kinase inhibitors |
| 06/12/2002 | EP1212317A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 06/12/2002 | EP1212306A2 Hydroxyalkanoylaminolactams and related structures as inhibitors of abeta protein production |
| 06/12/2002 | EP1212303A2 Bicyclic androgen and progesterone receptor modulator compounds and methods |